The global calcium D-pantothenate market is estimated to create an absolute dollar opportunity of around US$ 400 Mn by the end of 2032. The sales of calcium D-pantothenate are expected to exceed US$ 260 Mn by 2022, accelerating at a CAGR of around 4% to 5% during the forecast period 2022-2032. Surging demand for dietary supplements and infant nutrition with vitamin B5 derivatives such as calcium D-pantothenate is anticipated to bolster the growth in the global market.
| Report Attribute | Details |
| Calcium D-Pantothenate Market Base Year Value (2021) | US$ 253 Million |
| Calcium D-Pantothenate Market Expected Value (2022) | US$ 260 Million |
| Calcium D-Pantothenate Market Anticipated Value (2032) | US$ 400 Million |
| Calcium D-Pantothenate Market Projected Growth Rate (2022-2032) | 4% to 5% CAGR |
Calcium D-pantothenate is a derivative of vitamin B5 or pantothenic acid which is naturally present in plant and human cells. It is a calcium salt of water-soluble vitamin B5 which assist in the synthesis of acyl carrier proteins and coenzyme A (CoA). In appearance, calcium D-pantothenate is a white odorless powder and has a slight bitter taste. These calcium salts are highly soluble in water and insoluble in volatile solvents such as chloroform and ethers.
Demand for calcium salts such as calcium D-pantothenate is increasing at a rapid pace, owing to the increasing awareness regarding the benefits such as reducing skin pigmentation, increasing immunity, enhancing metabolic processes of the body, and assisting the body to synthesize lipids, proteins, and carbohydrates. With this surge in demand, calcium D-pantothenate is being synthetically produced for commercial activities and sold in the form of vitamin B5 supplements.
Thus, increasing customer inclination towards consumption of naturally sourced supplements and rising emphasis on production of calcium D-pantothenate extracted from plants to target growing vegan and vegetarian population is anticipated to drive the growth in the global market.
Calcium salts such as calcium D-pantothenate play a significant role in ensuring the effective functioning of the nervous system. Attributed to this, it is increasingly being used in the treatment and medication of neurological disorders. Hence, with surging demand for nutraceuticals for healthy cell & nerve functioning and rising emphasis on preventing muscle coordination and gastrointestinal complexities, calcium D-pantothenate is experiencing a rapid growth across pharmaceutical and supplement sectors.
Vitamin derivatives such as calcium D-pantothenate in gaining immense popularity across the cosmetics and personal care industry, owing to their benefits such as high antioxidant properties, reducing skin pigmentation, skin moisturizing, and protecting cells against peroxidative damage.
Over the past decade, a significant rise in hereditary conditions and diseases such as alopecia is being witnessed across the globe, increasing prevalence of hair loss. For instance, according to the National Alopecia Areata Foundation, approximately 147 million people globally are estimated to be suffering from hair loss diseases such as alopecia areata.
As calcium D-pantothenate provides essential nutrients to the scalp, nourishes follicles, strengthens hair roots, and stimulates the growth of new and existing hair, these vitamin B5 salts are increasingly being used in hair fall preventive supplement and products. Thus, increasing burden of aforementioned conditions is estimated to fuel the demand for calcium D-pantothenate in the market.
Despite several benefits associated with the consumption of calcium D-pantothenate, side effects of this B5 salts such as severe hives and skin rashes, difficulty in berating, nausea, hoarseness of voice, and peeling of skin among others are hindering the sales in the market.
In addition to this, the high cost of calcium D-pantothenate-based vitamin B5 supplements and increasing availability of low-cost alternatives such as pantothenic acid, dexpanthenol, and others are hampering the growth in the market.
Future Market Insights states that North America is estimated to account for the dominant share in the global calcium D-pantothenate market between 2022 and 2032.
As the trend of pet humanization continues to create deeper inroads across North America, a significant rise in adoption of pets such as dogs, cats, birds, fish, and others are being registered across countries such as the U.S. and Canada.
For instance, according to a report by the American Society for the Prevention of Cruelty to Animals, around 85 million families own at least one pet and nearly 4.1 million sheltered pets are adopted across the U.S. every year. As calcium D-pantothenate is increasingly used in pet supplements on the back of their health benefits, growing pet adoption is estimated to facilitate the growth in the North America market.
As per FMI, Asia Pacific Excluding Japan is anticipated to project rapid growth in the global calcium D-pantothenate market during the forecast period 2022-2032.
Calcium D-pantothenate is increasingly finding a wide range of applications across the cosmetics and beauty industry. It assists in hydrating skin, skin damage repair, reducing skin inflammation, moisturizing skin, and preventing bacteria from getting trapped in the pores. Thus, with rising emphasis on enhancing body and facial aesthetics, a swift rise in demand for cosmetics and beauty products is being witnessed.
Citing this trend, leading cosmetics product manufacturers are increasingly aiming at launching novel beauty supplements such as pills and cosmetics products with calcium D-pantothenate. This is projected to accelerate the sales of calcium D-pantothenate in the Asia Pacific Excluding Japan market.
Some of the leading players in the calcium D-pantothenate market are BASF, Shandong Xinfa Pharmaceutical, Alfa Aesar GmbH & Co KG, Avnochem Limited, Xinhua Pharmaceutical Co. Ltd, Shandong Hwatson Biochem, A. B. Enterprise, Global Calcium Pvt. Ltd., Supreem Pharmaceutical Mysore Pvt. Ltd., Shandong, Hebei Jingye Group, and others.
Prominent players in the global calcium D-pantothenate market are aiming at investing in capacity expansion to gain edge in the highly competitive market.
| Report Attribute | Details |
| Growth Rate | CAGR of 4% to 5% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Grade:
By Application:
By Region:
FMI projects the sales of calcium D-pantothenate in the market is expected to rise at 4% to 5% value CAGR by 2032
The global calcium D-pantothenate market is expected to be dominated by North America over the forecast period 2022-2032.
BASF, Shandong Xinfa Pharmaceutical, Alfa Aesar GmbH & Co KG, Avnochem Limited, Xinhua Pharmaceutical Co. Ltd, Shandong Hwatson Biochem, A. B. Enterprise, Global Calcium Pvt. Ltd., Supreem Pharmaceutical Mysore Pvt. Ltd., Shandong, Hebei Jingye Group, and others are some of the leading players in the prominent calcium D-pantothenate market.
Explore Similar Insights
Calcium D-Pantothenate Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
